4/14
10:53 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
10:53 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
09:48 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
09:48 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
07:48 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
07:48 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
07:31 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
07:31 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
07:13 am
syre
Spyre Therapeutics (SYRE) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Low
Report
Spyre Therapeutics (SYRE) had its "overweight" rating reaffirmed by Wells Fargo & Company.
4/14
06:42 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/14
06:42 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/13
04:07 pm
syre
Spyre Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Spyre Therapeutics initiated with a Strong Buy at Raymond James
4/13
04:07 pm
syre
Spyre Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Spyre Therapeutics initiated with a Strong Buy at Raymond James
4/13
03:54 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/13
03:29 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/13
03:29 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
4/13
03:07 pm
syre
Spyre Therapeutics (SYRE) had its "outperform" rating reaffirmed by Wedbush.
Low
Report
Spyre Therapeutics (SYRE) had its "outperform" rating reaffirmed by Wedbush.
4/13
03:07 pm
syre
Spyre Therapeutics (SYRE) had its "outperform" rating reaffirmed by Wedbush.
Low
Report
Spyre Therapeutics (SYRE) had its "outperform" rating reaffirmed by Wedbush.
4/13
01:07 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
3/31
08:02 am
syre
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
Medium
Report
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
3/31
06:29 am
syre
Rating for SYRE
High
Report
Rating for SYRE
3/18
01:31 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
3/16
12:47 pm
syre
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
3/16
12:22 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
2/24
06:48 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.